close Icon

Antibody Platforms

Burnet Institute is developing platforms to enhance efficacy of antibodies, Fc-fusion proteins, and antibody-like biologics that have potential application in oncology, infectious disease and immunological conditions.

Find us at BIO 2024 this June.

Stellabody Background Graphic4

A hexamerising technology that transforms the potency of monoclonal antibodies (mAb), Fc fusion prot...